Patient-reported benefit from proposed interventions to reduce financial toxicity during cancer treatment.

ABSTRACT:

Introduction

Financial toxicity is common and pervasive among cancer patients. Research suggests that gynecologic cancer patients experiencing financial toxicity are at increased risk for engaging in harmful cost-coping strategies, including delaying/skipping treatment because of costs, or forsaking basic needs to pay medical bills. However, little is known about patients' preferences for interventions to address financial toxicity.

Methods

Cross-sectional surveys to assess financial toxicity [Comprehensive Score for Financial Toxicity (COST)], cost-coping strategies, and preferences for intervention were conducted in a gynecologic cancer clinic waiting room. Associations with cost-coping were determined using multivariate modeling. Unadjusted odds ratios (ORs) explored asso

SUBMITTER: Aviki EM 

PROVIDER: S-EPMC9512060 | biostudies-literature | 2022 Mar

REPOSITORIES: biostudies-literature